Dawn M. Torres - Concepedia

Author

Dawn M. Torres

Brooke Army Medical Center ORCID

Also Known As

D M G TORRES, D M Torres, D. M. Torres, Dawn M Torres, Dawn M. Torres, Dawn McDowell Torres, Dawn Torres

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Brooke Army Medical Center Wilford Hall Ambulatory Surgical Center Joint Base San Antonio Walter Reed National Military Medical Center Texas Liver Institute

About

Dawn M. Torres is an author at Brooke Army Medical Center specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	9	4.4K
2	Gastroenterology	3	3	113
3	Health Sciences	2	3	898
4	Epidemiology	2	2	2.2K
5	Diabetes	1	1	22

Dawn M. Torres

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study Christopher D. Williams, Joel Z. Stengel, Michael Asike, Gastroenterology Metabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis	2010	2.2K
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension Naga Chalasani, Manal F. Abdelmalek, Guadalupe García–Tsao, Gastroenterology	2019	326
Association of Coffee and Caffeine Consumption With Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Degree of Hepatic Fibrosis Jeffrey W. Molloy, Christopher J. Calcagno, Christopher D. Williams, Hepatology	2011	314
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis Austin Nelson, Dawn M. Torres, Ana E. Morgan, Journal of Clinical Gastroenterology	2009	266
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial Dawn M. Torres, Frances J. Jones, Janet C. Shaw, Hepatology	2011	182
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial Carly S. Eckard, Renee E. Cole, Joshua Lockwood, Therapeutic Advances in Gastroenterology	2013	153
Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy†,‡ Stephen A. Harrison, Lorenzo Rossaro, Ke-Qin Hu, Hepatology	2010	144
Incidence of Bacteremia after Routine Tooth Brushing Joshua D. Hartzell, Dawn M. Torres, Peter Kim, The American Journal of the Medical Sciences Dental InfectionsOral HygieneDental DiseaseOral MicrobiologyMicrobiology	2005	59

Page 1